Atul
Atul
ChemicalsKey Fundamentals
SmallcapSpecialty ChemicalsChemicalsTapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
1- Company is almost debt free.
Weaknesses
3- Stock is trading at 2.95 times its book value
- The company has delivered a poor sales growth of 11.0% over past five years.
- Company has a low return on equity of 9.23% over last 3 years.
Growth Rate
AI Analysis — Bull vs Bear
Atul Ltd is a mid-cap specialty chemicals company with a market cap of ₹18,224 Cr trading at a PE of 23x and PB of 3x. The company is virtually debt-free and has shown a sharp TTM profit recovery of 59%, though its 5-year compounded profit growth stands at just 1% and 3-year ROE has averaged 9%, below what investors typically expect from the sector.
- The company is almost debt-free, giving it significant financial flexibility and low interest cost burden in a capital-intensive chemicals sector.
- TTM compounded profit growth has surged to 59%, indicating a strong earnings recovery cycle after a period of margin compression.
- TTM sales growth of 16% marks a notable acceleration compared to the 5-year compounded sales CAGR of 11% and 3-year CAGR of 5%.
- 10-year compounded sales CAGR of 9% and profit CAGR of 9% demonstrate a track record of steady long-term growth through multiple cycles.
- 10-year stock CAGR of 12% shows the company has delivered meaningful long-term wealth creation for patient shareholders.
- PE of 23x is moderate for a debt-free specialty chemicals company, especially in the context of a 59% TTM profit jump that could compress the forward multiple.
- Last year ROE improved to 11% from the 3-year average of 9%, suggesting a potential inflection in capital efficiency as earnings recover.
- 3-year ROE of just 9% is low for a specialty chemicals business, indicating suboptimal utilisation of shareholder equity over a meaningful period.
- 5-year compounded profit growth of only 1% shows the company struggled to translate revenue into bottom-line growth for an extended period.
- Stock price has delivered negative returns over 1-year (-1%), 3-year (-5%), and 5-year (-7%) horizons, reflecting sustained market scepticism.
- 5-year compounded sales growth of 11% is modest for a mid-cap chemicals player, and the 3-year figure drops further to just 5%.
- PB ratio of 3x means the stock trades at a significant premium to book value, which is harder to justify with a 3-year ROE of only 9%.
- Dividend yield of 0.47% offers minimal income cushion and suggests limited near-term shareholder return via dividends.
- 10-year ROE has trended down from 13% to 9% over 3 years, indicating a structural decline in return ratios rather than a one-off dip.
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
- New Independent Director Appointed Sep 7
Atul Ltd appointed Vinayak Deshpande as Independent Director for a five-year term, approved by shareholders via postal ballot and remote e-voting.
TL;DR: Limited recent news flow for Atul Ltd with only a routine board appointment announced. No material headwinds or positive catalysts emerged in the latest coverage. The appointment signals normal governance continuity. Investors should watch for upcoming quarterly results and chemical sector demand trends for directional cues.
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,182 | 1,194 | 1,138 | 1,212 | 1,322 | 1,393 | 1,417 | 1,452 | 1,478 | 1,552 | 1,574 | 1,670 | 1,848 |
| Expenses | 1,000 | 1,039 | 986 | 1,065 | 1,099 | 1,150 | 1,193 | 1,229 | 1,242 | 1,284 | 1,327 | 1,389 | 1,454 |
| Operating Profit | 182 | 155 | 152 | 148 | 223 | 243 | 224 | 223 | 236 | 267 | 247 | 281 | 394 |
| OPM % | 15% | 13% | 13% | 12% | 17% | 17% | 16% | 15% | 16% | 17% | 16% | 17% | 21% |
| Other Income | 10 | 24 | 17 | 16 | 16 | 35 | 19 | 50 | 28 | 50 | 40 | 92 | 35 |
| Interest | 2 | 2 | 2 | 5 | 5 | 9 | 4 | 5 | 5 | 5 | 4 | 4 | 4 |
| Depreciation | 52 | 54 | 61 | 76 | 77 | 78 | 81 | 82 | 82 | 81 | 80 | 79 | 78 |
| PBT | 138 | 124 | 105 | 83 | 158 | 191 | 158 | 186 | 177 | 231 | 203 | 289 | 347 |
| Tax % | 26% | 26% | 32% | 29% | 29% | 27% | 26% | 30% | 25% | 21% | 20% | 27% | 27% |
| Net Profit | 102 | 91 | 72 | 59 | 112 | 140 | 117 | 130 | 132 | 182 | 164 | 211 | 254 |
| EPS in Rs | 35.02 | 30.6 | 24.04 | 19.84 | 38 | 46.47 | 36.93 | 42.97 | 43.4 | 60.88 | 54.6 | 71.38 | 83.32 |
Profit & Loss
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,637 | 2,595 | 2,834 | 3,514 | 4,038 | 4,093 | 3,731 | 5,081 | 5,428 | 4,726 | 5,583 | 6,274 | 6,643 |
| Expenses | 2,235 | 2,134 | 2,324 | 3,008 | 3,270 | 3,191 | 2,813 | 4,168 | 4,620 | 4,086 | 4,665 | 5,240 | 5,455 |
| Operating Profit | 402 | 461 | 510 | 505 | 768 | 902 | 918 | 913 | 807 | 639 | 918 | 1,034 | 1,189 |
| OPM % | 15% | 18% | 18% | 14% | 19% | 22% | 25% | 18% | 15% | 14% | 16% | 16% | 18% |
| Other Income | 9 | 37 | 57 | 30 | 38 | 83 | 109 | 82 | 86 | 65 | 115 | 206 | 217 |
| Interest | 26 | 28 | 25 | 13 | 7 | 9 | 9 | 9 | 8 | 11 | 24 | 17 | 17 |
| Depreciation | 60 | 66 | 95 | 110 | 119 | 130 | 136 | 177 | 198 | 243 | 317 | 322 | 318 |
| PBT | 326 | 404 | 446 | 412 | 680 | 845 | 882 | 810 | 688 | 451 | 692 | 900 | 1,070 |
| Tax % | 31% | 32% | 28% | 32% | 36% | 21% | 25% | 25% | 26% | 28% | 28% | 23% | — |
| Net Profit | 240 | 274 | 323 | 281 | 436 | 671 | 660 | 605 | 507 | 324 | 499 | 689 | 811 |
| EPS in Rs | 81.13 | 92.44 | 109 | 93.21 | 146 | 225 | 222 | 204 | 174 | 110 | 164 | 230 | 270 |
| Div. Payout % | 10% | 9% | 9% | 13% | 10% | 12% | 9% | 12% | 19% | 18% | 15% | 13% | — |
Balance Sheet
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 29 | 29 | 29 |
| Reserves | 1,009 | 1,585 | 1,936 | 2,214 | 2,676 | 3,125 | 3,797 | 4,399 | 4,642 | 5,085 | 5,569 | 6,192 |
| Borrowings | 299 | 316 | 168 | 16 | 55 | 108 | 127 | 144 | 52 | 237 | 202 | 183 |
| Other Liabilities | 485 | 535 | 591 | 749 | 783 | 880 | 982 | 1,117 | 1,028 | 1,104 | 1,179 | 1,465 |
| Total Liabilities | 1,823 | 2,465 | 2,724 | 3,009 | 3,543 | 4,144 | 4,935 | 5,690 | 5,752 | 6,455 | 6,980 | 7,870 |
| Fixed Assets | 514 | 750 | 1,026 | 1,027 | 1,104 | 1,125 | 1,418 | 1,634 | 1,770 | 2,792 | 2,847 | 2,676 |
| CWIP | 112 | 180 | 59 | 96 | 172 | 368 | 250 | 420 | 1,033 | 281 | 124 | 110 |
| Investments | 66 | 382 | 429 | 470 | 752 | 1,137 | 1,361 | 1,339 | 881 | 1,392 | 1,766 | 2,592 |
| Other Assets | 1,131 | 1,154 | 1,210 | 1,415 | 1,515 | 1,513 | 1,906 | 2,297 | 2,068 | 1,990 | 2,242 | 2,492 |
| Total Assets | 1,823 | 2,465 | 2,724 | 3,009 | 3,543 | 4,144 | 4,935 | 5,690 | 5,752 | 6,455 | 6,980 | 7,870 |
Cash Flow
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 306 | 401 | 392 | 356 | 404 | 881 | 718 | 231 | 707 | 667 | 603 | 1,023 |
| Investing | -167 | -375 | -175 | -129 | -408 | -782 | -645 | -163 | -469 | -683 | -494 | -891 |
| Financing | -124 | -39 | -212 | -207 | -1 | -111 | -52 | -57 | -257 | 38 | -118 | -98 |
| Net Cash Flow | 16 | -13 | 5 | 19 | -5 | -11 | 21 | 11 | -20 | 22 | -9 | 34 |
| Free Cash Flow | 111 | 31 | 180 | 213 | 195 | 508 | 396 | -359 | -167 | 164 | 334 | 851 |
| CFO/OP | 95 | 111 | 93 | 91 | 86 | 122 | 100 | 47 | 112 | 121 | 82 | 113 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 61 | 62 | 67 | 75 | 63 | 64 | 72 | 71 | 57 | 72 | 74 | 74 |
| Inventory Days | 105 | 118 | 107 | 83 | 89 | 93 | 128 | 122 | 101 | 90 | 97 | 90 |
| Days Payable | 69 | 87 | 86 | 93 | 66 | 88 | 121 | 90 | 69 | 84 | 82 | 94 |
| Cash Conversion Cycle | 97 | 93 | 88 | 66 | 86 | 69 | 78 | 103 | 89 | 77 | 89 | 70 |
| Working Capital Days | 50 | 46 | 65 | 76 | 74 | 59 | 65 | 77 | 68 | 69 | 77 | 69 |
| ROCE % | 26% | 26% | 23% | 19% | 27% | 28% | 24% | 19% | 15% | 9% | 13% | 15% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Atul insights
63 extracted metrics + investor summaries across FY04–FY26.
Documents
Frequently Asked Questions about Atul
What does Atul Ltd do?
Where is Atul Ltd (ATUL) listed?
Which sector does Atul Ltd belong to?
What is the market capitalisation of Atul Ltd?
What is the PE ratio of Atul Ltd?
What is the 52-week high and low of Atul Ltd?
Does Atul Ltd pay dividends?
What is the Return on Equity (ROE) of Atul Ltd?
Company Information
Atul Ltd. is a diversified and integrated Indian chemical company (a part of Lalbhai Group, Gujarat). The products of the company are used in various Industries and come mainly under two segments, Life Science Chemicals and Performance and Other Chemicals under 9 Businesses. [1] Since its incorporation, the company has manufactured many products for the first time in India Dyes including Vat Dyes, crop care chemicals, Phosgene, Carbamite, 2,4-D Acid, para Cresol, tissue culture raised date palms. [2]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/ATUL.md for Atul Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.